Establishing a cancer genetics programme in Asia - The Singapore experience

Hereditary Cancer in Clinical Practice

Volumn 4, Issue 3, 2006, Pages 126-135

  Chieng, Wei Shieng ^a   Lee, Soo Chin ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Asia; Cancer genetics; Cancer genetics clinic; Genetic testing

Indexed keywords

ASIA; BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CONTINUING EDUCATION; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; POSTGRADUATE EDUCATION; PRIMARY PREVENTION; REVIEW; SINGAPORE;

EID: 33749321902     PISSN: 17312302     EISSN: None     Source Type: Journal    
DOI: 10.1186/1897-4287-4-3-126     Document Type: Review

References (34)

1. ASCO curriculum: Cancer genetics and cancer predisposition testing - Breast and Ovarian Cancer. Vol II; 1998.
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 206: 66-71.
3. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-2090.
4. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Green JS, Jass JR, Weber JL, Leach FS, et al. Genetic mapping of a locus predisposing to human colorectal cancer [see comments]. Science 1993; 260: 810-812.
5. Papadopoulos N and Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997; 10: 89-99.
6. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M and Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer [letter]. Nat Genet 1997; 17: 271-272.
7. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B and Kinzler KW. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-1987.
8. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, Kahn MJ, McTiernan A, Offit K, Thomson E and Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997; 277: 915-919.
9. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E and Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium [see comments]. JAMA 1997; 277: 997-1003.
10. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A and Mecklin JP. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer [see comments]. Gastroenterology 2000; 118: 829-834.
11. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT and Klijn JG. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345: 159-164.
12. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI and Weber BL. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002; 346: 1616-1622.
13. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM and Lu KH. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006; 354: 261-269.
14. Seow A, Koh WP, Chia KS, Shi LM, Lee HP and Shanmugaratnam K. Trends in Cancer Incidence in Singapore 1968-2002. Singapore Cancer Registry Report No. 6. 2004.
15. Singapore-Statistics-Department. Census of Population 2000. 2000: 4.
16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21: 2397-2406.
17. Ledger GA, Khosla S, Lindor NM, Thibodeau SN and Gharib H. Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med 1995; 122: 118-124.
18. Chiefari E, Russo D, Giuffrida D, Zampa GA, Meringolo D, Arturi F, Chiodini I, Bianchi D, Attard M, Trischitta V, Bruno R, Giannasio P, Pontecorvi A and Filetti S. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. J Endocrinol Invest 1998; 21: 358-364.
19. Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C and Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508-517.
20. Yong MC, Zhou XJ and Lee SC. The importance of paternal family history in hereditary breast cancer is underappreciated by health care professionals. Oncology 2003; 64: 220-226.
21. Chin TM, Tan SH, Lim SE, Iau P, Yong WP, Wong SW and Lee SC. Acceptance, motivators, and barriers in attending breast cancer genetic counselling in Asians. Cancer Detect Prev 2005; 29: 412-418.
22. Lee SC, Guo JY, Lim R, Soo R, Koay E, Salto-Tellez M, Leong A and Goh BC. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia. Clin Genet 2005; 68: 137-145.
23. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M and Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-433.
24. Lee SC, Bernhardt BA and Helzlsouer KJ. Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution. Cancer 2002; 94: 1876-1885.
25. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J and Burke W. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 1999; 8: 369-375.
26. Landsbergen K, Verhaak C, Kraaimaat F and Hoogerbrugge N. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 2005; 4: 115-119.
27. Rajkumar T, Soumittra N, Vidubula E, Sridevi V, Mahajan V, Ramanan SG and Vijaya S. Organization and running of the first comprehensive hereditary cancer clinic in India. Hereditary Cancer in Clinical Practice 2005; 3: 165-170.
28. Glanz K, Grove J, Lerman C, Gotay C and Le Marchand L. Correlates of intentions to obtain genetic counselling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 1999; 8: 329-336.
29. Eisenbruch M, Yeo SS, Meiser B, Goldstein D, Tucker K and Barlow-Stewart K. Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Soc Sci Med 2004; 59: 235-248.
30. Huang X, Butow P, Meiser B and Goldstein D. Attitudes and information needs of Chinese migrant cancer patients and their relatives. Aust N Z J Med 1999; 29: 207-213.
31. Benowitz S. To tell the truth: a cancer diagnosis in other cultures is often a family affair. J Natl Cancer Inst 1999; 91: 1918-1919.
32. Westbrook MT, Legge V and Pennay M. Attitudes towards disabilities in a multicultural society. Soc Sci Med 1993; 36: 615-623.
33. Wainberg S and Husted J. Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 2004; 13: 1989-1995.
34. Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT and Narod S. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 2005; 4: 97-103.